Break it Down: EBR Systems’ heart failure study published in prestigious journal

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on EBR Systems’ (ASX:EBR) pivotal trial results published in a prestigious US, peer-reviewed journal.

By pacing endocardially in the left ventricle, EBR’s WiSE CRT system opens a window for the future care of patients with heart failure.

Tune in to get the latest.

While EBR Systems is a Stockhead advertiser, it did not sponsor this content.